Home › Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results For Memory Deficits
 

Keywords :   


Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results For Memory Deficits

2015-11-03 05:00:12| drugdiscoveryonline News Articles

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, recently presented new positive preclinical efficacy data for memory deficits at the Society for Neuroscience annual meeting in Chicago

Tags: results reports positive memory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »